Maze Therapeutics MAZE EBIT

EBIT at other companies

Vertex PharmaceuticalsVRTX

$1.25B+8.3%

Septerna, Inc.SEPN

-$16.84M+41.9%

Stoke Therapeutics, Inc.STOK

-$53.42M-148%

Olema Pharmaceuticals, Inc.OLMA

-$57.99M-66.3%

Nurix Therapeutics, Inc.NRIX

-$94.2M-95.0%

Apogee Therapeutics, Inc.APGE

-$82.77M-31.2%

FAQ

What is Maze Therapeutics's EBIT?

Maze Therapeutics (MAZE) reported EBIT of -$48.04M in Q2 2026.

How has Maze Therapeutics's EBIT changed year-over-year?

Maze Therapeutics's EBIT decreased by 31.7% year-over-year, from -$36.47M to -$48.04M.

What does EBIT mean?

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.